Nykode Therapeutics AS (FRA:5VB)
0.1884
+0.0049 (2.67%)
Last updated: Dec 1, 2025, 2:13 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of €61.02 million as of December 1, 2025. Its market cap has increased by 1.41% in one year.
Market Cap
61.02M
Enterprise Value
9.24M
Revenue
6.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.19
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 549.42M to 61.02M, a decrease of -88.89%. That is a compound annual growth rate of -31.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 59.87M | -28.98% |
| Dec 30, 2024 | 84.29M | -86.48% |
| Dec 29, 2023 | 623.47M | -20.78% |
| Dec 30, 2022 | 787.04M | -66.41% |
| Dec 30, 2021 | 2.34B | 15.26% |
| Dec 30, 2020 | 2.03B | 270.00% |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |